Dimensional Fund Advisors LP Myriad Genetics Inc Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Myriad Genetics Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,423,477 shares of MYGN stock, worth $33.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,423,477
Previous 2,776,959 12.73%
Holding current value
$33.1 Million
Previous $67.9 Million 2.35%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$23.97 - $28.6 $8.47 Million - $10.1 Million
-353,482 Reduced 12.73%
2,423,477 $66.3 Million
Q2 2024

Aug 09, 2024
BUY
$17.98 - $25.47 $1.36 Million - $1.92 Million
75,445 Added 2.79%
2,776,959 $67.9 Million
Q1 2024

May 10, 2024
BUY
$17.59 - $23.59 $362,283 - $485,859
20,596 Added 0.77%
2,701,514 $57.6 Million
Q4 2023

Feb 07, 2024
BUY
$13.91 - $21.32 $1.24 Million - $1.9 Million
89,330 Added 3.45%
2,680,918 $51.3 Million
Q3 2023

Nov 09, 2023
SELL
$15.99 - $23.22 $1.31 Million - $1.9 Million
-81,883 Reduced 3.06%
2,591,588 $41.6 Million
Q2 2023

Aug 09, 2023
SELL
$17.56 - $23.76 $894,242 - $1.21 Million
-50,925 Reduced 1.87%
2,673,471 $62 Million
Q1 2023

May 12, 2023
BUY
$15.26 - $23.75 $1.38 Million - $2.15 Million
90,532 Added 3.44%
2,724,396 $63.3 Million
Q4 2022

Feb 09, 2023
BUY
$14.51 - $20.99 $2.92 Million - $4.23 Million
201,414 Added 8.28%
2,633,864 $38.2 Million
Q3 2022

Nov 10, 2022
SELL
$18.21 - $27.88 $1.98 Million - $3.03 Million
-108,757 Reduced 4.28%
2,432,450 $46.4 Million
Q2 2022

Aug 12, 2022
SELL
$16.45 - $25.88 $324,673 - $510,793
-19,737 Reduced 0.77%
2,541,207 $46.2 Million
Q1 2022

May 13, 2022
SELL
$22.67 - $28.01 $1.7 Million - $2.1 Million
-74,859 Reduced 2.84%
2,560,944 $64.5 Million
Q4 2021

Feb 09, 2022
SELL
$24.13 - $32.63 $1.22 Million - $1.65 Million
-50,573 Reduced 1.88%
2,635,803 $72.7 Million
Q3 2021

Nov 12, 2021
SELL
$29.97 - $36.66 $2.47 Million - $3.02 Million
-82,328 Reduced 2.97%
2,686,376 $86.7 Million
Q2 2021

Aug 12, 2021
BUY
$25.39 - $32.61 $960,376 - $1.23 Million
37,825 Added 1.39%
2,768,704 $84.7 Million
Q1 2021

May 14, 2021
SELL
$19.92 - $31.6 $620,667 - $984,592
-31,158 Reduced 1.13%
2,730,879 $82.9 Million
Q4 2020

Feb 25, 2021
BUY
$12.16 - $19.77 $33.6 Million - $54.6 Million
2,762,037 New
2,762,037 $54.6 Million

Others Institutions Holding MYGN

# of Institutions
253
Shares Held
90.5M
Call Options Held
100K
Put Options Held
34K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.1B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email